GeoVax Labs, Inc. is a clinical-stage biotechnology company with a robust pipeline of human vaccines and immunotherapies to address unmet medical needs in cancer and infectious disease.
$0.90 +0.09 (10.75%)
As of 02/01/2023 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.